Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai No 1 Pharmacy Co's quarterly market cap
declined
from Sep. 2025 (¥3,070 Mil) to Dec. 2025 (¥2,885 Mil) and
declined
from Dec. 2025 (¥2,885 Mil) to Mar. 2026 (¥2,684 Mil).
Shanghai No 1 Pharmacy Co's annual market cap
increased
from Dec. 2023 (¥2,681 Mil) to Dec. 2024 (¥3,012 Mil) but then
declined
from Dec. 2024 (¥3,012 Mil) to Dec. 2025 (¥2,885 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai No 1 Pharmacy Co's Enterprise Value for Today is ¥1,935 Mil.
Shanghai No 1 Pharmacy Co (SHSE:600833) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Shanghai No 1 Pharmacy Co Market Cap Related Terms
Shanghai No 1 Pharmacy Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai No 1 Pharmacy Co Market Cap Competitor Comparison
For the Pharmaceutical Retailers subindustry, Shanghai No 1 Pharmacy Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai No 1 Pharmacy Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shanghai No 1 Pharmacy Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Shanghai No 1 Pharmacy Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai No 1 Pharmacy Co (SHSE:600833) has a Market Cap of ¥2,095 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shanghai No 1 Pharmacy Co and its competitors. According to the industry distribution chart, Shanghai No 1 Pharmacy Co ranks #237 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 34.1%.
Is Shanghai No 1 Pharmacy Co's Market Cap too high?
Shanghai No 1 Pharmacy Co's current Market Cap is ¥2,095 Mil. Based on the distribution chart, Shanghai No 1 Pharmacy Co ranks #237 out of 695 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Shanghai No 1 Pharmacy Co ranks #237 out of 695 companies for Market Cap. This puts Shanghai No 1 Pharmacy Co in the upper half of its industry. The industry median Market Cap is 103.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.28, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shanghai No 1 Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai No 1 Pharmacy Co's current Market Cap is ¥2,095 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.83, compared to a current price of ¥9.39 — trading 26.8% below its estimated fair value. The current Market Cap is ¥2,095 Mil. Shanghai No 1 Pharmacy Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current Market Cap is ¥2,095 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued.
The current stock price of ¥9.39 is trading 26.8% below its estimated GF Value™ of ¥12.83.
GuruFocus considers Shanghai No 1 Pharmacy Co to be Modestly Undervalued.
Key valuation signals for SHSE:600833:
Market Cap: ¥2,095 Mil
GF Value™: ¥12.83 vs. price of ¥9.39 (26.8% below fair value)
No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
56GF Score
Get the complete analysis for SHSE:600833
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600833 has been successfully added to your 
